AL Amyloidosis Diagnostic Market Size
Market Size in USD Bn
CAGR7.00%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 7.00% |
| Market Concentration | High |
| Major Players | Janssen Pharmaceuticals, Prothena, AstraZeneca (Caelum Biosciences), Bristol-Myers Squibb, Oncopeptides AB and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
AL Amyloidosis Diagnostic Market Analysis
The AL amyloidosis diagnostic market is estimated to be valued at USD 1.14 billion in 2025 and is expected to reach USD 1.83 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.00% from 2025 to 2032.
The market is experiencing positive growth due to the increasing prevalence of AL amyloidosis and rising awareness about the disease. In addition, rising healthcare expenditure and growing geriatric population are also propelling the market growth.